The canonical and non-canonical NF-κB pathways are persistently activated in cancer cells through IKK and NIK6, 7, 37, 38, 39, although the molecular mechanisms of IKK and NIK activation are not completely understood. The gene discussed is NFKB1; the disease is cancer.